Jasper Therapeutics faces financial challenges but strong buy ratings. Read why JSPR stock is poised for growth amid risks ...

Muvalaplin shows promise in lowering lipoprotein(a) levels, which are genetically determined and confer cardiovascular risk ...

In today’s fast-paced world, the connection between our mind and body often gets overlooked. Yet, research continually highlights the profound impact that mental well-being has on physical health and ...

With continuous advancement of the Belt and Road Initiative, Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. has been actively promoting the globalization of traditional Chinese medicine (TCM) ...

Hon Hai Technology Group ("Foxconn") (TWSE:2317), in partnership with two Taiwanese hospitals, has been selected for the Taiwan government-backed "Big A+" program that will give the world's largest ...

A supplement with a heavy social media presence is raising some eyebrows in the medical community for suggesting that it helps kids grow taller. It’s called TruHeight, and the supplement claims to ...

Vasoactive Intestinal Peptide (VIP) is an intriguing neuropeptide with a wide range of potential biological impacts, primarily hypothesized in tissues, cells, and internal systems. Since its discovery ...

This clinical trial is made possible through Sen-Jam's novel and inclusive ... "This innovative solution is about promoting human health and maximizing productivity by supporting individuals who ...

A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a), according to late-breaking science presented today at the ...

The community-focused well-being social club in Montclair will welcome Harvard stress expert and author Dr. Aditi Nerurkar on Thursday, Nov. 21.

In recent years, the landscape of substance abuse has shifted significantly, marked by a surge in mortality rates linked to ...

FDA IND approval for TB006 is a major achievement for TrueBinding and a significant potential advancement for the treatment of Parkinson’s Disease worldwide,” said Alan K. Jacobs, M.D., FAAN, Chief ...